McKesson raised its full-year profit outlook as specialty-drug distribution and oncology services expanded, strengthening the case for its shift toward more specialized healthcare services.
Read the full research in the app
A subscription is required to access the full thread.
Open in the app →Financials
Technicals
Earnings-peers